Come up with a name for your new list and we'll add to it:
Rhythm Pharmaceuticals raised a round of funding on September 11, 2013. Investors include
The Michael J. Fox Foundation.
Rhythm Pharmaceuticals is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm is developing the ghrelin peptide agonist, RM-131, for the trea…